SME Times is powered by   
Search News
Just in:   • Adani Group to invest Rs 57,575 crore in Odisha  • 'Dollar Distancing' finally happening? Time for India to pitch Rupee as credible alternative: SBI Ecowrap  • 49% Indian startups now from tier 2, 3 cities: Jitendra Singh  • 'India ranks 3rd in global startup ecosystem & number of unicorns'  • LinkedIn lays off entire global events marketing team: Report 
Last updated: 27 Sep, 2014  

Agriculture.9.thmb.jpg Medicinal plants exports jump 137 percent

Agriculture.9.jpg
   Top Stories
» 49% Indian startups now from tier 2, 3 cities: Jitendra Singh
» 'India ranks 3rd in global startup ecosystem & number of unicorns'
» Tripura exported over 9K tonnes of pineapples in 2 years
» CPI inflation eases to 6.71% in July, IIP falls to 12.3%
» Rupee depreciates 12 paise to close at 79.64 against US dollar
SME Times News Bureau | 09 Aug, 2012
India continues to be ranked the world's second largest exporter of medicinal plants after China as the trade in herbals registered around 137 percent growth in last five years, an official said Wednesday.

According to the Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoepathy (AYUSH), India has 5,662 varieties of medicinal plants and of these trading takes place in 460, while 178 are exported in huge quantities (over 100 metric tonnes per year).

The department is part of the union health ministry and works to propagate Indian systems of medicine.

"India ranks second in the world after China in export of medicinal plants. The global trade of medicinal plants stands at $7,592 million in 2011, and of these China and India's share was around $1,329 million and $790 million respectively," Anil Kumar, secretary (AYUSH), told reporters.

India has registered a growth of 137 percent in export of medicinal plants in global market from Rs.554 crore in 2005-06 to Rs.1,318 crore in 2010-11.

Several schemes have been initiated to maintain the growth of herbal exports.

The department has taken several steps to deal with the quality control issues of Ayurveda, Unani, Siddha and Homoepathy drugs in India.

"These include notification of the shelf life for drugs, amendment in labelling and licensing provisions and initiating action for setting up of a more effective central regulatory mechanism," Kumar said.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 13 Aug, 2022
  Daily Poll
PM Modi's recent US visit to redefine India-US bilateral relations
 Yes
 No
 Can't say
  Commented Stories
» GIC Re's revenue from obligatory cession threatened(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter